FIELD: medicine, experimental phthisiology. SUBSTANCE: method involves administration of taufon on the background of treatment with isoniazide being taufon is administrated in the dose 15 mg/kg every day for two months, not less. This invention promotes to the enhancement of efficiency of treatment of experimental tuberculosis. Invention can be used in treatment of experimental tuberculosis. EFFECT: improved method of treatment, expanded assortment of preparation used. 2 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING THE CASES OF EXPERIMENTAL TUBERCULOSIS | 2000 |
|
RU2165761C1 |
| METHOD FOR TREATING THE CASES OF TUBERCULOSIS | 2002 |
|
RU2212240C1 |
| ANTI-TUBERCULOSIS PREPARATION | 2002 |
|
RU2211035C1 |
| METHOD OF STIMULATION OF IMMUNOBIOLOGICAL RESISTANCE | 1996 |
|
RU2148995C1 |
| TUBERCULOSTATIC AGENT | 2002 |
|
RU2207126C1 |
| METHOD TO INCREASE RESISTANCE TO XENOBIOTICS IN EXPERIMENTAL ANIMALS | 1998 |
|
RU2178712C2 |
| METHOD FOR TREATING TUBERCULOSIS | 2004 |
|
RU2269346C1 |
| METHOD OF REDUCING INTOLERANCE TO ANTITUBERCULOUS PREPARATIONS | 2009 |
|
RU2412701C2 |
| METHOD FOR IMMUNOMODULATION IN EXPERIMENTAL ANIMALS | 1995 |
|
RU2112549C1 |
| METHOD FOR TREATMENT OF DESTRUCTIVE AND PROGRESSING LUNG TUBERCULOSIS FORMS CAUSED BY DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS | 2000 |
|
RU2215538C2 |
